All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Solid Organ Transplantation Hub is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View solid organ transplantation content recommended for you
Guidelines from the American Association for the Study of Liver Diseases (AASLD), the American Society of Transplantation (AST), and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) on the evaluation of pediatric liver transplantation (LT) candidates were published in Hepatology by Martinez et al. A total of 90 guidelines were developed by a multidisciplinary writing group, aiming to provide updated evidence-based recommendations that reflect current best practice and evolving clinical knowledge.
Key data: Recommendations include urgent referral of all pediatric patients with acute liver failure to a LT center for evaluation, and consideration of LT evaluation for those with chronic liver disease who experience a decompensating event. The evaluation process should be standardized and involve a multidisciplinary team to establish the need and optimal timing for transplantation, identify potential barriers, and address the child’s needs and family readiness. All age-appropriate inactivated and live vaccines should be administered to LT candidates and household contacts before transplantation using an accelerated schedule, when necessary, except in children with acute liver failure. LT candidates should receive measles–mumps–rubella and varicella vaccines starting at 6 months of age. LT should not be performed in patients with uncontrolled sepsis, progressive systemic disease not amenable to treatment with an LT, unresectable extrahepatic malignancy, severe multisystem mitochondrial disease, or irreversible cerebral edema with uncal herniation. Retransplantation should be considered for patients with graft failure that cannot be managed otherwise, with evaluation conducted at an experienced center.
Key learning: These guidelines provide evidence-based recommendations for the evaluation of pediatric LT candidates, covering indications and contraindications for transplantation, pre-transplantation assessment, and the importance of a coordinated, multidisciplinary approach.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.